15
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Ondansetron, a New Antiemetic Therapy for Oncology

Pages 55-61 | Published online: 08 Jul 2009
 

Abstract

The nausea and emesis associated with chemotherapy still constitute an important problem in anticancer treatment. The new specific 5-HT, receptor antagonists appear to be effective against vomiting induced by chemotherapy and radiation. An overview is given of the current theories on the physiology of emesis and the available literature on ondansetron (GR38032F) as an antiemetic.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.